26 - 50 of 122
Number of results to display per page
TitleCreatorDate
26 Central Retinal Artery Occlusion With Subsequent Central Retinal Vein Occlusion in Biopsy-Proven Giant Cell ArteritisZoë R. Williams, MD; Xiaofei Wang, MD, PhD; David A. DiLoreto Jr, MD, PhD2016-09
27 Central Trochlear Palsy: Report of Two Patients With Ipsilesional Palsy and Review of the LiteratureSeong-Hae Jeong, MD; Sung-Hee Kim, MD; Seung-Han Lee, MD, PhD; Seong-Ho Park, MD, PhD; Hyo-Jung Kim, PhD; Ji-Soo Kim, MD, PhD2016-12
28 Chronic Myelogenous Leukemia Relapse Presenting With Central Nervous System Blast Crisis and Bilateral Optic Nerve InfiltrationJoyce N. Mbekeani, MD, FRCS, FRCOphth; Maaly Abdel Fattah, MD, PhD; Randa M. Al Nounou, MD; Wahiba Chebbo, MD; Mohammed Asif Dogar, MD2016-03
29 Chronic Progressive External Ophthalmoplegia in the Absence of PtosisRobert C. Bucelli, MD, PhD; Michael S. Lee, MD; Collin M. McClelland, MD2016-09
30 Cigarette Smoking and Activities of Daily Living in Ocular Myasthenia GravisSean M. Gratton, MD; Angela M. Herro, MD; William J. Feuer, MS; Byron L. Lam, MD2016-03
31 Cilioretinal Artery Territory Infarction Associated With Papilledema in a Patient With Neurofibromatosis Type 2Omar A. Mahroo, PhD, FRCOphth; Moin D. Mohamed, PhD, FRCOphth; Elizabeth M. Graham, FRCOphth; Samantha S. Mann, MD, FRCOphth; Gordon T. Plant, MD, FRCP; Shazia K. Afridi, MRCP, PhD; Christopher J. Hammond, MD, FRCOphth2016-03
32 Cobalt-Chromium Metallosis With Normal ElectroretinogramLola M. Grillo, BA; Huy V. Nguyen, MD; Stephen H. Tsang, MD, PhD; Donald C. Hood, PhD; Jeffrey G. Odel, MD2016-12
33 Congenital Tonic Pupils Associated With Congenital Central Hypoventilation Syndrome and Hirschsprung DiseaseViraj J. Mehta, MD, MBA; Joseph J. Ling, BA; Elizabeth G. Martinez, DO; Anvesh C. Reddy, MD; Sean P. Donahue, MD, PhD2016-12
34 Delayed Development of Intracranial Hypertension After Discontinuation of Tetracycline Treatment for Acne VulgarisChristine Law, MD; Gary L. Yau, MD; Martin ten Hove, MEng, MD, FRCSC2016-03
35 Development of Dural Arteriovenous Fistulas After Cerebral Venous Sinus ThrombosisJonathan A. Micieli, MD, CM; Sheldon Derkatch, MD; Vitor M. Pereira, MD; Edward A. Margolin, MD2016-03
36 Diagnosis of Tensilon-Negative Ocular Myasthenia Gravis By Daily SelfieElan L. Guterman, MD; James V. Botelho, AB; Jonathan C. Horton, MD, PhD2016-09
37 Diagnostic Algorithm for Patients With Suspected Giant Cell Arteritis Useful, but No Substitute for Thorough HistopathologyAdarsh George, Bmed; Nicole S. Lim, BMed; Neeranjali S. Jain, BMed (Hons); Calum W. K. Chong, BMed; Farshad Abedi, MD, DMed; ScYing Liu, MBBS; Sarah B. Wang, BA (Hons); Matt Govendir, BSc (Hons); Ashish Agar, FRANZCO, PhDIan; C. Francis, FRACS, PhD2016-09
38 Diagnostic Algorithm for Patients With Suspected Giant Cell Arteritis' Useful, but No Substitute for Thorough Histopathology: ResponseM. Tariq Bhatti, MD; Mays A. El-Dairi, MD; Thomas J. Cummings, MD; Alan D. Proia, MD2016-09
39 Diagnostic Algorithm for Patients With Suspected Giant Cell Arteritis: CommentSohan S. Hayreh, MD, MS, PhD, DSc, FRCS, FRCOphth (Hon)2016-06
40 Diagnostic Algorithm for Suspected Giant Cell Arteritis: ResponseM. Tariq Bhatti, MD, Mays A. El-Dairi, MD; Thomas J. Cummings, MD; Alan D. Proia, MD2016-06
41 Difficulties in Daily Life Reported by Patients with Homonymous Visual Field Defects: ErratumCristian M. Salgado, MD2016-09
42 Does Nocturnal Hypotension Play a Causal Role in Nonarteritic Anterior Ischemic Optic Neuropathy?Dean M. Cestari, MD; Anthony Arnold, MD2016-09
43 Does Treatment of Ocular Myasthenia Gravis With Early Immunosuppressive Therapy Prevent Secondarily Generalization and Should It Be Offered to All Such Patients?Sui H. Wong, MRCP; Gordon T. Plant, FRCP, FRCOphth; Wayne Cornblath, MD2016-03
44 Dyschromatopsia in Multiple Sclerosis Patients: A Marker of Subclinical Involvement?Helena Felgueiras, MD; Joana Parra, MD; Simão Cruz, MD; Pedro Pereira, MD; Ana F. Santos, MD; Adriana Rua, MD; Dália Meira, MD; Pedro Fonseca, MD; Catarina Pedrosa, MD; João N. Cardoso, MD; Cristina Almeida, MD; Maria Araújo, MD, Ernestina Santos, MD2016-09
45 Factors Affecting Visual Field Outcomes in the Idiopathic Intracranial Hypertension Treatment TrialKimberly E. Cello, BS; John L. Keltner, MD; Chris A. Johnson, PhD; Michael Wall, MD for the NORDIC Idiopathic Intracranial Hypertension Study Group2016-03
46 Finding NMO: The Evolving Diagnostic Criteria of Neuromyelitis OpticaJeffrey L. Bennett, MD, PhD2016-09
47 Fixation Switch DiplopiaStacy L. Pineles, MD2016-06
48 Food and Drug Administration Adverse Event Reports of Retinal Vascular Occlusions Associated With Phosphodiesterase Type 5 Inhibitor UseAlbert S. Li, MD; Howard D. Pomeranz, MD, PhD2016-12
49 Giant Cell ArteritisCourtney E. Francis, MD2016-03
50 Giant Cell Arteritis With Arteritic Anterior Ischemic Optic Neuropathy Is Bilateral Until Proven OtherwiseNandini Singh, BMed; Adarsh George, BMed; Jeremy Tan, BMed, MD; Shaun Y. P. Ewe, MBBS, BMedSci; Ian C. Francis, FRACS, PhD2016-12
26 - 50 of 122